Anti-cancer shots for boys in the pipeline

NewsGuard 100/100 Score

The Pharmaceutical Benefits Advisory Committee (PBAC) is deciding on whether to include the human papillomavirus (HPV) vaccine, Gardasil in in the National Immunization Program for boys.

At present Gardasil is administered to girls when they begin high school to prevent cervical cancer. HPV, however, also causes throat cancer, genital and anal warts, and cancer of the penis. About 90 per cent of all anal squamous cell carcinomas are caused by infection with HPV. Anal cancer had increased by about 3.4 per cent annually in men and 1.9 per cent in women since 1982, according to the study published in the journal Vaccine.

Gardasil is approved in Australia for use in boys and men aged nine to 26. Without subsidy, it costs $450 a treatment, and most parents are unaware of the protection it offers boys. According to Professor Andrew Grulich, of the National Centre in HIV Epidemiology and Clinical Research, only few boys from medical families are getting the shots. He said, “The boys who are getting it more than any others are the sons of doctors because doctors are aware of the enormous benefits of this vaccine for boys… There is absolutely no doubt it will prevent most anal cancer, that it will prevent quite a bit of penile cancer, and that it will prevent almost all anal and genital warts.”

Grulich pointed out that HPV was now responsible for majority of cancers in the back of the throat in Australia due to lower rates of smoking, and oral sex growing in acceptability. “Those cancers have been increasing over the last 20 or 30 years. Previously we thought perhaps 20 or 30 percent of those cancers were caused by HPV and now it’s more like 70 percent…It’s really important that this vaccine should be given before the onset of sexual activity because once a man becomes sexually active this virus is so common that he will become infected with it really quite quickly…It should be part of the school vaccination program. It should be given at exactly the same age as girls, and on the same day as the girls are done,” he said.

According to the CSL Limited, which holds the license for the drug in Australia, this is a cost effective submission to the PBAC. If PBAC supports the submission, it will go to the health minister by midyear. Sharon McHale, CSL’s senior director of public affairs is hopeful that males could be included in the immunization program by next year. “The prevalence and severity of HPV disease in males is considerable and justifies a universal vaccination program… A gender-neutral vaccination strategy will have the greatest impact on HPV disease and is in the best interest of public health,” McHale said.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Anti-cancer shots for boys in the pipeline. News-Medical. Retrieved on April 18, 2024 from

  • MLA

    Mandal, Ananya. "Anti-cancer shots for boys in the pipeline". News-Medical. 18 April 2024. <>.

  • Chicago

    Mandal, Ananya. "Anti-cancer shots for boys in the pipeline". News-Medical. (accessed April 18, 2024).

  • Harvard

    Mandal, Ananya. 2018. Anti-cancer shots for boys in the pipeline. News-Medical, viewed 18 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NCCN 2024 Annual Conference focuses on practical applications for improving cancer care